03:42 PM EST - Sirona Biochem Corp. : announced that its Chief Business Development Officer, Attila Hajdu, will be presenting at BIO-Europe on November 4 at the International Congress Centre in Munich, Germany. New results from the glycoprotein program for anti-aging and regenerative medicine will be presented, including positive efficacy data and potential new collaborative projects with cosmetic companies. Sirona Biochem Corp.
shares V.SBM are trading unchanged at $0.16.
